Abnormal DDR1 expression is detected in a range of solid tumors (including breast, ovarian, cervical, liver, gastric, colorectal, lung, and brain) [29–35] and is associated with aggressive metastatic tumors (including breast and ovarian) and poor prognosis [24, 36–38]. This evidence concerns the gene DDR1 and metastatic neoplasm.